Fentanyl sublingual spray for breakthrough cancer pain in patients receiving transdermal fentanyl.

about

A fixed inhaled nitrous oxide/oxygen mixture as an analgesic for adult cancer patients with breakthrough pain: study protocol for a randomized controlled trial.Fentanyl Formulations in the Management of Pain: An Update.

P2860

Q37579153-5B1FE81B-AE1E-4D28-9F96-CDA1039A0FCA Q39197889-29BEAF04-810F-49D8-BCF8-C2F544F18F2E

P2860

Fentanyl sublingual spray for breakthrough cancer pain in patients receiving transdermal fentanyl.

Item

http://www.wikidata.org/entity/Q38394314

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Fentanyl sublingual spray for ...... eceiving transdermal fentanyl.

@en

type

Item

label

Fentanyl sublingual spray for ...... eceiving transdermal fentanyl.

@en

prefLabel

Fentanyl sublingual spray for ...... eceiving transdermal fentanyl.

@en

P1476

Fentanyl sublingual spray for ...... eceiving transdermal fentanyl.

@en

P2093

Christina Cognata Smith

http://www.w3.org/2001/XMLSchema#string

David S Alberts

http://www.w3.org/2001/XMLSchema#string

Neha Parikh

http://www.w3.org/2001/XMLSchema#string

Richard L Rauck

http://www.w3.org/2001/XMLSchema#string

P2860

Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease

A titration strategy is needed to manage breakthrough cancer pain effectively: observations from data pooled from three clinical trials.

Breakthrough pain: definition, prevalence and characteristics.

Equianalgesic dose ratios for opioids. a critical review and proposals for long-term dosing.

Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain.

Drug delivery via the mucous membranes of the oral cavity.

The role of fentanyl in cancer-related pain.

Fentanyl for breakthrough pain: a systematic review.

Prevalence of breakthrough cancer pain: a systematic review and a pooled analysis of published literature.

Single-dose pharmacokinetics of fentanyl sublingual spray and oral transmucosal fentanyl citrate in healthy volunteers: a randomized crossover study.

P304

427-434

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PMT-2015-0009

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27020837

http://www.w3.org/2001/XMLSchema#string

P921

fentanyl

Fentanyl sublingual spray for breakthrough cancer pain in patients receiving transdermal fentanyl.

about

P2860

P2860

Fentanyl sublingual spray for breakthrough cancer pain in patients receiving transdermal fentanyl.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921